10
Oct
2019

Share

CPG brands miss another opportunity

Consumer packaged goods brands have been working to keep up with new world trends for some time now. The introduction of more affordable private label products and the general shift to be fresher and healthier have left the major brands behind. The latest trend to catch companies like Kellogg and General Mills behind has been the resurgence of snack bars.

Research group Mintel reported that snack bar sales in the US grew 3.9 per cent last year, an acceleration on previous years’ growth; however, the underlying division of sales is more telling. According to Nielsen, classic cereal and granola bars have been in decline for years, down 3.7 per cent in the latest year through August. Meanwhile, health and nutrition bars are growing strongly, holding up the group as consumers reach for ‘healthier’ high protein low sugar alternatives.

Screen Shot 2019-10-09 at 3.33.34 pm

CPG brands, late to the table, are beginning to shift their offering to account for the new meaning of healthy. General Mills reported that US retail sales of snack bars dropped 4 per cent in its latest quarter. The company said they are making progress in improving their products, such as a crispy-wafer Nature Valley bar and a low sugar Fiber One bar. Meanwhile, Kellogg CEO Steve Callihane admitted the group needs to “do a better job at innovating and making our foods relevant for today’s beliefs.”

Large companies are also using their size to invest in smaller, more popular brands. However, investments in the current market come at a high cost. Hershey recently purchased One for US$397 million and Simply Good Food bought Quest Nutrition for US$1 billion. Mondelez took a majority stake in Perfect Bar and Kellogg in 2017 bought Rxbar, at the peak of its popularity.

Unfortunately, it is tough to jump into such a competitive market with little room for innovative growth. Rxbar was popularised years ago as the first natural protein bar, made from dates and egg whites. Since Kellogg has taken ownership, the product now “has all kinds of copycats,” according to Rxbar’s chief marketing officer.

Consumer preferences, along with their definition of healthy, are constantly changing. Tragically for these already struggling CPG companies, the latest trend is yet another strategic shift that they were late to act on, leaving them to decide between spending up on hopeful acquisitions or missing the boat entirely.

The Montaka Funds are short shares in Kellogg. This article was prepared 10 October with the information we have today, and our view may change. It does not constitute formal advice or professional investment advice. If you wish to trade Kellogg you should seek financial advice.

Our Funds

The Montgomery Fund

  • AUSTRALIA/NZ
  • Concentrated high conviction equities
  • From $25,000
Learn More

Montgomery Global Fund

  • GLOBAL
  • Concentrated high conviction equities
  • From $25,000
Learn More

Montgomery Alpha Plus Fund

  • GLOBAL
  • A market neutral strategy
  • From $50,000
Learn More

Montaka Global Access Fund

  • GLOBAL
  • Access long/short global equity portfolio
  • From $50,000
Learn More

Montgomery Global Equities Fund (ASX:MOGL)

  • GLOBAL
  • Concentrated high conviction equities
  • No minimum investment - see your broker limits
Learn More

Montgomery Small Companies Fund

  • AUSTRALIA/NZ
  • Concentrated high conviction equities
  • From $25,000
Learn More
Close

Our Funds

Concentrated High Conviction Equities

Listed

Montgomery Global Equities Fund (ASX:MOGL)

Global
Available on the ASX as an Exchange Traded Managed Fund, invests in 15 to 30 quality global businesses for long-term capital growth with a target distribution yield of 4.5% per annum. Mirrors the strategy of the Montgomery Global Fund.
Unlisted From $25,000

Montgomery Global Fund

Global
Invests in 15 to 30 quality global businesses for long-term capital growth. Priced daily. Mirrors the strategy of the Montgomery Global Equities Fund (ASX:MOGL).
Unlisted from $25,000

The Montgomery Fund

Australia/NZ
Aims to provide long-term growth and income by investing in 20 to 40 high-quality Australian and New Zealand businesses trading at attractive valuations. Priced daily.
New Fund

Montgomery Small Companies Fund

Australia/NZ
Aims to provide long-term growth by investing in 30 to 50 high quality, undervalued, Australian and NZ small and emerging companies with strong growth potential. Priced daily.
Unlisted from $1 Million

The Montgomery [Private] Fund

Australia/NZ
Seeks to deliver absolute returns from a portfolio of high-quality Australian and New Zealand businesses. Capital preservation is paramount. By invitation only.

Alternate Equity Strategies

Unlisted from $50,000

Montgomery Alpha Plus Fund

Global
Aims to generate positive returns in both rising and falling markets. Invests in 80 to 180 global businesses expected to deliver above-average returns, while selling short a similar-sized portfolio expected to deliver below-average returns. Priced daily.
Unlisted from $50,000

Montaka Global Access Fund

Global
Aims to generate materially higher risk-adjusted returns, net of fees, than is generally available in the equities market over the medium term. Priced monthly. Provides retail investors access to the Montaka Global Fund.
Unlisted From $1 Million

Montaka Global Fund

Global
Aims to generate materially higher risk-adjusted returns, net of fees, than is generally available in the equities market over the medium term. By invitation only.